Wanbangde Pharmaceutical Holding Group Co Ltd

SHE:002082 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.48 Billion
CN¥10.85 Billion CNY
Market Cap Rank
#8211 Global
#1522 in China
Share Price
CN¥17.74
Change (1 day)
+3.02%
52-Week Range
CN¥5.23 - CN¥19.57
All Time High
CN¥25.24
About

Wanbangde Pharmaceutical Holding Group Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicine, chemical raw materials, and chemical preparations in China and internationally. The company operates through two segments, the Pharmaceutical Business and the Medical Device Business. It offers drugs products used to treat cardiovascular and cerebrovascul… Read more

Wanbangde Pharmaceutical Holding Group Co Ltd (002082) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: 0.000x

Based on the latest financial reports, Wanbangde Pharmaceutical Holding Group Co Ltd (002082) has a cash flow conversion efficiency ratio of 0.000x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-1.04 Million) by net assets (CN¥2.77 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Wanbangde Pharmaceutical Holding Group Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2024)

This chart illustrates how Wanbangde Pharmaceutical Holding Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Wanbangde Pharmaceutical Holding Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Wanbangde Pharmaceutical Holding Group Co Ltd ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Wanbangde Pharmaceutical Holding Group Co Ltd (2003–2024)

The table below shows the annual cash flow conversion efficiency of Wanbangde Pharmaceutical Holding Group Co Ltd from 2003 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥2.76 Billion CN¥120.22 Million 0.044x +265.13%
2023-12-31 CN¥2.76 Billion CN¥-72.87 Million -0.026x +68.93%
2022-12-31 CN¥2.82 Billion CN¥-239.65 Million -0.085x -1156.46%
2021-12-31 CN¥2.74 Billion CN¥22.09 Million 0.008x -84.77%
2020-12-31 CN¥2.86 Billion CN¥151.01 Million 0.053x +140.62%
2019-12-31 CN¥1.91 Billion CN¥-248.69 Million -0.130x -265.60%
2018-12-31 CN¥1.72 Billion CN¥135.40 Million 0.079x +815.48%
2017-12-31 CN¥1.60 Billion CN¥-17.60 Million -0.011x -104.93%
2016-12-31 CN¥1.40 Billion CN¥310.71 Million 0.222x +1687.76%
2015-12-31 CN¥1.35 Billion CN¥16.76 Million 0.012x -88.50%
2014-12-31 CN¥1.30 Billion CN¥140.31 Million 0.108x -45.14%
2013-12-31 CN¥1.19 Billion CN¥234.35 Million 0.197x +6.79%
2012-12-31 CN¥1.10 Billion CN¥202.73 Million 0.185x +13651.98%
2011-12-31 CN¥1.05 Billion CN¥-1.44 Million -0.001x -100.79%
2010-12-31 CN¥936.13 Million CN¥162.26 Million 0.173x +106.47%
2009-12-31 CN¥811.59 Million CN¥68.13 Million 0.084x -76.37%
2008-12-31 CN¥712.31 Million CN¥253.06 Million 0.355x +1084.23%
2007-12-31 CN¥415.12 Million CN¥12.45 Million 0.030x +206.57%
2006-12-31 CN¥357.72 Million CN¥3.50 Million 0.010x -86.67%
2005-12-31 CN¥152.88 Million CN¥11.23 Million 0.073x -69.41%
2004-12-31 CN¥136.17 Million CN¥32.69 Million 0.240x -36.09%
2003-12-31 CN¥98.53 Million CN¥37.01 Million 0.376x --